Search Videos and More

Showing 37 - 48 of 50 results

Previous| 1... 3 | 4 | 5 |Next


Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology News

Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology

Throughout Susan Sippel’s career at Fox Chase, three things have stood out: mentors, connecting with patients, and teamwork. She joined Fox Chase 29 years ago as a ward secretary for the Three South unit after her sister-in-law, a Fox Chase nurse, told her about the opening. Three years later, she moved into patient care as a nursing assistant—a title she’s held proudly for 26 years.
CivaSheet<sup>®</sup> for precise radiation delivery for pancreatic cancer News

CivaSheet® for precise radiation delivery for pancreatic cancer

CivaSheet®?is an FDA-approved Pd-103 brachytherapy planar radiation source that is radioactive on only one side. It is designed to safely deliver high doses of radiation to precisely targeted areas.
Patient-Reported Quality of Life Research May Guide Treatment Decisions for Lower-Risk Prostate Cancer News

Patient-Reported Quality of Life Research May Guide Treatment Decisions for Lower-Risk Prostate Cancer

New research from clinical investigators at Fox Chase may help men with prostate cancer in selecting the appropriate type of radiation therapy to treat their disease.
Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients News

Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients

In a recent study, Fox Chase Cancer Center researchers sought to identify predictors of concern in men who recently underwent treatment for prostate cancer.
Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery News

Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery

Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.
International Collaborations Help Optimize Partial Nephrectomy Techniques News

International Collaborations Help Optimize Partial Nephrectomy Techniques

The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.
Identification and Management of Immunotherapy Toxicities News

Identification and Management of Immunotherapy Toxicities

The NCCN and ASCO have developed new guidelines that describe which bodily systems can be affected by immunotherapy and how to manage side effects based on their severity.
Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment News

Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment

With so many different kinds of sarcoma that can be easily misdiagnosed in settings where they aren’t frequently seen, Fox Chase’s expertise in sarcoma care and its multidisciplinary team approach provide patients with more treatment options.?
PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer News

PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer

The use of PARP inhibitors has changed the way ovarian cancer is treated and has improved outcomes.
Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials News

Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials

Recognizing the need for further evaluation of immunotherapy for breast cancer treatment, Fox Chase Cancer Center has opened two investigator-initiated trials exploring the use of immunotherapy for triple-negative and HER2-positive breast cancer.
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care News

Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical trial selection for solid tumors may not be as accurate as they are thought to be, according to a new study by researchers at Fox Chase Cancer Center.
De-escalating Treatment for Bladder and Prostate Cancers News

De-escalating Treatment for Bladder and Prostate Cancers

Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. Here are some lessons Fox Chase Cancer Center researchers are learning about these de-escalation approaches.

Showing 37 - 48 of 50 results

Previous| 1... 3 | 4 | 5 |Next